DK2585085T3 - Anvendelse af lactobacilli, der inhiberer gasproducerende coliforme bakterier isoleret fra spædbørn ramt af kolik - Google Patents

Anvendelse af lactobacilli, der inhiberer gasproducerende coliforme bakterier isoleret fra spædbørn ramt af kolik

Info

Publication number
DK2585085T3
DK2585085T3 DK10743216.3T DK10743216T DK2585085T3 DK 2585085 T3 DK2585085 T3 DK 2585085T3 DK 10743216 T DK10743216 T DK 10743216T DK 2585085 T3 DK2585085 T3 DK 2585085T3
Authority
DK
Denmark
Prior art keywords
lactobacilli
colic
coliform bacteria
bacteria isolated
inhibit gas
Prior art date
Application number
DK10743216.3T
Other languages
English (en)
Inventor
Gianna Scatizzi
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Application granted granted Critical
Publication of DK2585085T3 publication Critical patent/DK2585085T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/25Lactobacillus plantarum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)
DK10743216.3T 2010-06-28 2010-06-28 Anvendelse af lactobacilli, der inhiberer gasproducerende coliforme bakterier isoleret fra spædbørn ramt af kolik DK2585085T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2010/001554 WO2012001440A1 (en) 2010-06-28 2010-06-28 Use of lactobacilli inhibiting gas producing coliform bacteria isolated from infants affected by colic

Publications (1)

Publication Number Publication Date
DK2585085T3 true DK2585085T3 (da) 2014-06-23

Family

ID=42989661

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10743216.3T DK2585085T3 (da) 2010-06-28 2010-06-28 Anvendelse af lactobacilli, der inhiberer gasproducerende coliforme bakterier isoleret fra spædbørn ramt af kolik

Country Status (11)

Country Link
US (1) US9255246B2 (da)
EP (1) EP2585085B1 (da)
JP (1) JP2013531506A (da)
CN (1) CN103079580B (da)
BR (1) BR112012033212B1 (da)
DK (1) DK2585085T3 (da)
ES (1) ES2491619T3 (da)
PL (1) PL2585085T3 (da)
RU (1) RU2544054C2 (da)
UA (1) UA107711C2 (da)
WO (1) WO2012001440A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110679A1 (it) * 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITRM20110475A1 (it) * 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
CA2944407A1 (en) * 2014-03-28 2015-10-01 Conjugon, Inc. Preparation of small colony variants of therapeutic bacteria
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
CN114647779A (zh) * 2015-08-12 2022-06-21 爱康迪健康规划服务股份有限公司 信息处理装置、信息处理方法和记录介质
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
CA3013280A1 (en) * 2016-02-12 2017-08-17 Probiotical S.P.A. Use of bacterial strains belonging to the species lactobacillus kefiri in paediatrics to generate and/or maintain a state of homeostasis
ITUB20160708A1 (it) * 2016-02-12 2017-08-12 Probiotical Spa Uso di ceppi di batteri appartenenti alla specie Lactobacillus kefiri in pediatria per generare e/o mantenere lo stato di omeostasi.
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
KR102135195B1 (ko) * 2018-10-08 2020-07-17 아주대학교산학협력단 테트라제노코커스 할로필러스를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
CN113142396A (zh) * 2021-06-11 2021-07-23 中国农业大学 一种制备豆科牧草青贮饲料用菌剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040161422A1 (en) 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
CA2549115C (en) * 2002-09-26 2013-07-16 Vita-Herb Nutriceuticals, Inc. Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
JP4387972B2 (ja) * 2005-04-14 2009-12-24 大洋香料株式会社 抗酸化剤
RU2391393C1 (ru) 2008-11-19 2010-06-10 Галина Геннадиевна Алехина ШТАММ Lactobacillus delbrueckii TS1-06, ИСПОЛЬЗУЕМЫЙ ДЛЯ ИЗГОТОВЛЕНИЯ БАКТЕРИАЛЬНЫХ ПРЕПАРАТОВ И ПРОИЗВОДСТВА ЖИДКОЙ МОЛОЧНОКИСЛОЙ ЗАКВАСКИ В КАЧЕСТВЕ ПРОДУКТА ПИТАНИЯ ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОГО НАЗНАЧЕНИЯ

Also Published As

Publication number Publication date
WO2012001440A1 (en) 2012-01-05
ES2491619T3 (es) 2014-09-08
CN103079580B (zh) 2015-04-29
JP2013531506A (ja) 2013-08-08
UA107711C2 (en) 2015-02-10
US20130195823A1 (en) 2013-08-01
US9255246B2 (en) 2016-02-09
BR112012033212A2 (pt) 2016-10-25
RU2544054C2 (ru) 2015-03-10
EP2585085A1 (en) 2013-05-01
PL2585085T3 (pl) 2014-10-31
EP2585085B1 (en) 2014-05-28
BR112012033212B1 (pt) 2021-06-08
RU2013102424A (ru) 2014-08-10
CN103079580A (zh) 2013-05-01

Similar Documents

Publication Publication Date Title
NO2021032I1 (no) Verisiguat og dens salter, solvater og solvater av salter
PL2585085T3 (pl) Zastosowanie Lactobacilli hamujących wytwarzające gaz gram-ujemne pałeczki jelitowe izolowane od niemowląt z kolką
EP2552241A4 (en) PROCESS FOR PREPARING D-PSICOSE CRYSTALS
HRP20181190T1 (hr) SPOJEVI KOJI SU KORISNI ZA LIJEČENJE AIDS-a
ME03475B (me) Antiparazitske kompozicije dihidroazola
DK3251678T3 (da) Benzoxaborolderivater til behandling af bakterieinfektioner
PL2477638T3 (pl) Stabilizacja probiotyku
HRP20180809T1 (hr) Inhibicijski spojevi metaloenzima
BR112014003878A2 (pt) síntese de r-bifenilalaninol
PL2588067T3 (pl) Kompozycja dla zdrowia jamy ustnej
HRP20180851T1 (hr) Postupak za mineralizaciju ugljikovog dioksida
HRP20190171T1 (hr) Udobna ortopedska stolica za prevenciju bolesti kralježnice
SG10201510800PA (en) Purification of flaviviruses
IT1393136B1 (it) Procedimento per la preparazione del bosentan
EP2691361A4 (en) SYNTHESIS OF DIAZIDEN
FR2941939B1 (fr) Preparation de chlorure de calcium epure
EP2690972A4 (en) GLUCOSYLSTEVIA COMPOSITION
HUE036319T2 (hu) 2-karboxamid-cikloamino-karbamidszármazékok szintézise
EP2575555A4 (en) Drinking mouthpiece
BR112014009185A2 (pt) estabilização de polióis brutos da biomassa
SMT201600126B (it) Solfonammidi per la prevenzione del diabete
ZA201202514B (en) Use of cyclic keto-enols for combating plant pathogenic bacteria
EP2593096A4 (en) DICLOFENAC SALT OF TRAMADOL
EP2595966A4 (en) SYNTHESIS OF CYCLOPENTACHINAZOLINES
ZA201502787B (en) Residual disinfection of water